Likarda Reaffirms Strong Momentum and Continued Execution Following Leadership Transition
Kansas City, MO – January 23, 2026 – Likarda, a leader in hydrogel-based drug delivery and cell therapy enabling technologies, today announced that Dr. Stella Vnook has stepped down from her role as Chief Executive Officer. The transition marks the completion of a planned leadership period during which Stella was instrumental in increasing Likarda’s visibility, strengthening strategic partnerships, and positioning the company for its next phase of growth.
